Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2019

Open Access 01-12-2019 | Tetralogy of Fallot | Research

Tetralogy of Fallot in Spain: a nationwide registry-based mortality study across 36 years

Authors: Laura Llamosas-Falcón, Eva Bermejo-Sánchez, Germán Sánchez-Díaz, Ana Villaverde-Hueso, Manuel Posada de la Paz, Verónica Alonso-Ferreira

Published in: Orphanet Journal of Rare Diseases | Issue 1/2019

Login to get access

Abstract

Background

Tetralogy of Fallot (TOF) is the most frequent cyanotic congenital heart defect. TOF mortality has fallen remarkably in recent years due to therapeutic advances. Accordingly, the aim of this study was to assess temporal and spatial variability in TOF-related mortality in Spain across the period 1981–2016, using data drawn from the nationwide population-based registry.

Methods

Annual deaths due to TOF were sourced from the Spanish National Institute of Statistics database by reference to International Classification of Diseases (ICD), 9th and 10th Revision codes, namely, ICD-9 code 745.2 (period 1981–1998) and ICD-10 code Q21.3 (period 1999–2016). Age-specific and age-adjusted mortality rates were calculated, as were standardised mortality ratios (SMRs) by province, district and municipality for the period 1999–2016.

Results

A total of 1035 deaths were attributed to TOF (57.78% of them were men and 42.22% were women). The age-adjusted mortality rate ranged from 0.75 per 1,000,000 inhabitants (95% confidence interval [CI]: 0–1.36) in 1981 to 0.03 per 1,000,000 (95% CI: 0.01–0.06) in 2016 for both sexes. In 2011, there was a change in the mortality trend, with a significant decrease of 49.22% per year (p < 0.001). In terms of geographical analysis, some areas with a significantly higher risk of TOF mortality were identified in the south of Spain, though no specific spatial pattern was in evidence.

Conclusion

The decrease in TOF mortality may be related to improvements in diagnostic and treatment techniques. More studies are needed to analyse regions with a higher mortality risk, in order to improve medical planning and resource allocation, and identify risk factors and preventive measures.
Literature
1.
2.
go back to reference Anderson RH, Weinberg PM. The clinical anatomy of tetralogy of Fallot. Cardiol Young. 2005;15(S1):38.PubMedCrossRef Anderson RH, Weinberg PM. The clinical anatomy of tetralogy of Fallot. Cardiol Young. 2005;15(S1):38.PubMedCrossRef
4.
go back to reference Alonso V, Villaverde-Hueso A, Hens M, Morales-Piga A, Abaitua I, Posada de la Paz M. Public health research on rare diseases. Georgian Med News. 2011;(193):11–6. Alonso V, Villaverde-Hueso A, Hens M, Morales-Piga A, Abaitua I, Posada de la Paz M. Public health research on rare diseases. Georgian Med News. 2011;(193):11–6.
5.
go back to reference van der Linde D, Konings EEM, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJM, et al. Birth prevalence of congenital heart disease worldwide. J Am Coll Cardiol. 2011;58(21):2241–7.PubMedCrossRef van der Linde D, Konings EEM, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJM, et al. Birth prevalence of congenital heart disease worldwide. J Am Coll Cardiol. 2011;58(21):2241–7.PubMedCrossRef
6.
go back to reference Pedersen LM, Pedersen TAL, Ravn HB, Hjortdal VE. Outcomes of pregnancy in women with tetralogy of Fallot. Cardiol Young. 2008;18(04).PubMedCrossRef Pedersen LM, Pedersen TAL, Ravn HB, Hjortdal VE. Outcomes of pregnancy in women with tetralogy of Fallot. Cardiol Young. 2008;18(04).PubMedCrossRef
7.
go back to reference Pérez-Lescure Picarzo J, Mosquera González M, Latasa Zamalloa P, Crespo Marcos D. Incidencia y evolución de las cardiopatías congénitas en España durante 10 años (2003-2012). An Pediatría. 2018;89(5):294-301. Pérez-Lescure Picarzo J, Mosquera González M, Latasa Zamalloa P, Crespo Marcos D. Incidencia y evolución de las cardiopatías congénitas en España durante 10 años (2003-2012). An Pediatría. 2018;89(5):294-301.
8.
go back to reference Morris JK, Springett AL, Greenlees R, Loane M, Addor M-C, Arriola L, et al. Trends in congenital anomalies in Europe from 1980 to 2012. Palazón-Bru A, editor. PLoS One 2018;13(4):e0194986.PubMedPubMedCentralCrossRef Morris JK, Springett AL, Greenlees R, Loane M, Addor M-C, Arriola L, et al. Trends in congenital anomalies in Europe from 1980 to 2012. Palazón-Bru A, editor. PLoS One 2018;13(4):e0194986.PubMedPubMedCentralCrossRef
9.
go back to reference Alonso-Ferreira V, Sánchez-Díaz G, Villaverde-Hueso A, Posada de la Paz M, Bermejo-Sánchez EA. Nationwide registry-based study on mortality due to rare congenital anomalies. Int J Environ Res Public Health. 2018;15(8):1715.PubMedCentralCrossRef Alonso-Ferreira V, Sánchez-Díaz G, Villaverde-Hueso A, Posada de la Paz M, Bermejo-Sánchez EA. Nationwide registry-based study on mortality due to rare congenital anomalies. Int J Environ Res Public Health. 2018;15(8):1715.PubMedCentralCrossRef
10.
go back to reference Bertranou EG, Blackstone EH, Hazelrig JB, Turner ME Jr, Kirklin JW. Life expectancy without surgery in tetralogy of Fallot. Am J Cardiol. 1978;42(3):458–66.PubMedCrossRef Bertranou EG, Blackstone EH, Hazelrig JB, Turner ME Jr, Kirklin JW. Life expectancy without surgery in tetralogy of Fallot. Am J Cardiol. 1978;42(3):458–66.PubMedCrossRef
11.
go back to reference Niwa K, Hamada H, Nakazawa M, Terai M, Tateno S, Sugimoto S, et al. Mortality and risk factors for late deaths in tetralogy of Fallot: the Japanese Nationwide multicentric survey. Cardiol Young. 2002;12(5):453–60.PubMedCrossRef Niwa K, Hamada H, Nakazawa M, Terai M, Tateno S, Sugimoto S, et al. Mortality and risk factors for late deaths in tetralogy of Fallot: the Japanese Nationwide multicentric survey. Cardiol Young. 2002;12(5):453–60.PubMedCrossRef
12.
go back to reference Mathers C, Boerma T. Mortality measurement matters: improving data collection and estimation methods for child and adult mortality. PLoS Med. 2010;7(4):e1000265.PubMedPubMedCentralCrossRef Mathers C, Boerma T. Mortality measurement matters: improving data collection and estimation methods for child and adult mortality. PLoS Med. 2010;7(4):e1000265.PubMedPubMedCentralCrossRef
13.
go back to reference Knott-Craig CJ, Elkins RC, Lane MM, Holz J, McCue C, Ward KE. A 26-year experience with surgical management of tetralogy of fallot: risk analysis for mortality or late reintervention. Ann Thorac Surg. 1998;66(2):506–10.PubMedCrossRef Knott-Craig CJ, Elkins RC, Lane MM, Holz J, McCue C, Ward KE. A 26-year experience with surgical management of tetralogy of fallot: risk analysis for mortality or late reintervention. Ann Thorac Surg. 1998;66(2):506–10.PubMedCrossRef
14.
go back to reference Ismail SR, Kabbani MS, Najm HK, Abusuliman RM, Elbarbary M. Early outcome of tetralogy of Fallot repair in the current era of management. J Saudi Heart Assoc. 2010;22(2):55–9.PubMedPubMedCentralCrossRef Ismail SR, Kabbani MS, Najm HK, Abusuliman RM, Elbarbary M. Early outcome of tetralogy of Fallot repair in the current era of management. J Saudi Heart Assoc. 2010;22(2):55–9.PubMedPubMedCentralCrossRef
15.
go back to reference Cohen KE, Buelow MW, Dixon J, Brazauskas R, Cohen SB, Earing MG, et al. Forced vital capacity predicts morbidity and mortality in adults with repaired tetralogy of Fallot. Congenit Heart Dis. 2017;12(4):435–40.PubMedCrossRef Cohen KE, Buelow MW, Dixon J, Brazauskas R, Cohen SB, Earing MG, et al. Forced vital capacity predicts morbidity and mortality in adults with repaired tetralogy of Fallot. Congenit Heart Dis. 2017;12(4):435–40.PubMedCrossRef
16.
go back to reference Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010;56(14):1149–57.PubMedCrossRef Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010;56(14):1149–57.PubMedCrossRef
17.
go back to reference Greutmann M, Tobler D, Kovacs AH, Greutmann-Yantiri M, Haile SR, Held L, et al. Increasing mortality burden among adults with complex congenital heart disease. Congenit Heart Dis. 2015;10(2):117–27.PubMedCrossRef Greutmann M, Tobler D, Kovacs AH, Greutmann-Yantiri M, Haile SR, Held L, et al. Increasing mortality burden among adults with complex congenital heart disease. Congenit Heart Dis. 2015;10(2):117–27.PubMedCrossRef
18.
go back to reference Engelfriet P, Boersma E, Oechslin E, Tijssen J, Gatzoulis MA, Thilén U, et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. Eur Heart J. 2005;26(21):2325–33.PubMedCrossRef Engelfriet P, Boersma E, Oechslin E, Tijssen J, Gatzoulis MA, Thilén U, et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. Eur Heart J. 2005;26(21):2325–33.PubMedCrossRef
19.
go back to reference Caruana M, Grech V. A first population-based long-term outcome study in adults with repaired tetralogy of Fallot in Malta. Congenit Heart Dis. 2017;12(3):301–8.PubMedCrossRef Caruana M, Grech V. A first population-based long-term outcome study in adults with repaired tetralogy of Fallot in Malta. Congenit Heart Dis. 2017;12(3):301–8.PubMedCrossRef
20.
go back to reference Hickey EJ, Veldtman G, Bradley TJ, Gengsakul A, Manlhiot C, Williams WG, et al. Late risk of outcomes for adults with repaired tetralogy of Fallot from an inception cohort spanning four decades. Eur J Cardiothorac Surg. 2009;35(1):156–64.PubMedCrossRef Hickey EJ, Veldtman G, Bradley TJ, Gengsakul A, Manlhiot C, Williams WG, et al. Late risk of outcomes for adults with repaired tetralogy of Fallot from an inception cohort spanning four decades. Eur J Cardiothorac Surg. 2009;35(1):156–64.PubMedCrossRef
21.
go back to reference Chiu S-N, Wang J-K, Chen H-C, Lin M-T, Wu E-T, Chen C-A, et al. Long-term survival and unnatural deaths of patients with repaired tetralogy of Fallot in an Asian cohort. Circ Cardiovasc Qual Outcomes. 2012;5(1):120–5.PubMedCrossRef Chiu S-N, Wang J-K, Chen H-C, Lin M-T, Wu E-T, Chen C-A, et al. Long-term survival and unnatural deaths of patients with repaired tetralogy of Fallot in an Asian cohort. Circ Cardiovasc Qual Outcomes. 2012;5(1):120–5.PubMedCrossRef
22.
go back to reference Nollert G, Fischlein T, Bouterwek S, Böhmer C, Klinner W, Reichart B. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol. 1997;30(5):1374–83.PubMedCrossRef Nollert G, Fischlein T, Bouterwek S, Böhmer C, Klinner W, Reichart B. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol. 1997;30(5):1374–83.PubMedCrossRef
23.
go back to reference Zhao Y, Abuhamad A, Fleenor J, Guo Y, Zhang W, Cao D, et al. Prenatal and postnatal survival of fetal tetralogy of Fallot: a meta-analysis of perinatal outcomes and associated genetic disorders. J Ultrasound Med. 2016;35(5):905–15.PubMedCrossRef Zhao Y, Abuhamad A, Fleenor J, Guo Y, Zhang W, Cao D, et al. Prenatal and postnatal survival of fetal tetralogy of Fallot: a meta-analysis of perinatal outcomes and associated genetic disorders. J Ultrasound Med. 2016;35(5):905–15.PubMedCrossRef
24.
go back to reference García A, Caicedo M, Moreno K, Sandoval N, Ronderos M, Dennis R. Diferencias regionales en cardiopatías congénitas. Rev Colomb Cardiol. 2017;24(2):161–8. García A, Caicedo M, Moreno K, Sandoval N, Ronderos M, Dennis R. Diferencias regionales en cardiopatías congénitas. Rev Colomb Cardiol. 2017;24(2):161–8.
25.
go back to reference Miao C-Y, Zuberbuhler JS, Zuberbuhler JR. Prevalence of congenital cardiac anomalies at high altitude. J Am Coll Cardiol. 1988;12(1):224–8.PubMedCrossRef Miao C-Y, Zuberbuhler JS, Zuberbuhler JR. Prevalence of congenital cardiac anomalies at high altitude. J Am Coll Cardiol. 1988;12(1):224–8.PubMedCrossRef
26.
go back to reference Nelson JS, Stebbins RC, Strassle PD, Meyer RE. Geographic distribution of live births with tetralogy of Fallot in North Carolina 2003 to 2012: tetralogy of Fallot in NC. Birt Defects Res A Clin Mol Teratol. 2016;106(11):881–7.CrossRef Nelson JS, Stebbins RC, Strassle PD, Meyer RE. Geographic distribution of live births with tetralogy of Fallot in North Carolina 2003 to 2012: tetralogy of Fallot in NC. Birt Defects Res A Clin Mol Teratol. 2016;106(11):881–7.CrossRef
27.
go back to reference Cavero Carbonell C, Zurriaga O, Pérez Panadés J, Barona Vilar C, Martos Jiménez C. Variación temporal y distribución geográfica de las cardiopatías congénitas en la Comunitat Valenciana. An Pediatría. 2013;79(3):149–56.CrossRef Cavero Carbonell C, Zurriaga O, Pérez Panadés J, Barona Vilar C, Martos Jiménez C. Variación temporal y distribución geográfica de las cardiopatías congénitas en la Comunitat Valenciana. An Pediatría. 2013;79(3):149–56.CrossRef
28.
go back to reference Prats P, Ferrer Q, Rodríguez M. Diagnóstico prenatal y evolución de cardiopatías congénitas. Diagn Prenat. 2011;22(4).CrossRef Prats P, Ferrer Q, Rodríguez M. Diagnóstico prenatal y evolución de cardiopatías congénitas. Diagn Prenat. 2011;22(4).CrossRef
29.
go back to reference Poon LCY, Huggon IC, Zidere V, Allan LD. Tetralogy of Fallot in the fetus in the current era. Ultrasound Obstet Gynecol. 2007;29(6):625–7.PubMedCrossRef Poon LCY, Huggon IC, Zidere V, Allan LD. Tetralogy of Fallot in the fetus in the current era. Ultrasound Obstet Gynecol. 2007;29(6):625–7.PubMedCrossRef
30.
go back to reference Nelle M, Raio L, Pavlovic M, Carrel T, Surbek D, Meyer-Wittkopf M. Prenatal diagnosis and treatment planning of congenital heart defects—possibilities and limits. World J Pediatr. 2009;5(1):18–22.PubMedCrossRef Nelle M, Raio L, Pavlovic M, Carrel T, Surbek D, Meyer-Wittkopf M. Prenatal diagnosis and treatment planning of congenital heart defects—possibilities and limits. World J Pediatr. 2009;5(1):18–22.PubMedCrossRef
31.
go back to reference Allan LD, Sharland GK. Prognosis in fetal tetralogy of Fallot. Pediatr Cardiol. 1992;13:4. Allan LD, Sharland GK. Prognosis in fetal tetralogy of Fallot. Pediatr Cardiol. 1992;13:4.
32.
go back to reference Bajo Arenas JM, Pérez Medina T, Haya Palazuelos J. Sistemática de la exploración ecográfica durante la gestación. In: Tratado de ginecología y Obstetricia y Medicina de la reproducción. Madrid: Cabero L, Ed. Editorial Panamericana; 2003. p. 343–50. ISBN 3084-7903-754-7. Bajo Arenas JM, Pérez Medina T, Haya Palazuelos J. Sistemática de la exploración ecográfica durante la gestación. In: Tratado de ginecología y Obstetricia y Medicina de la reproducción. Madrid: Cabero L, Ed. Editorial Panamericana; 2003. p. 343–50. ISBN 3084-7903-754-7.
33.
go back to reference Sociedad Española de Ginecología y Obstetricia. Control prenatal del embarazo normal. Prog Obstet Ginecol. 2011;54(6):281-350. Sociedad Española de Ginecología y Obstetricia. Control prenatal del embarazo normal. Prog Obstet Ginecol. 2011;54(6):281-350.
35.
go back to reference Loomba RS, Buelow MW, Woods RK. Complete repair of tetralogy of Fallot in the neonatal versus non-neonatal period: a meta-analysis. Pediatr Cardiol. 2017;38(5):893–901.PubMedCrossRef Loomba RS, Buelow MW, Woods RK. Complete repair of tetralogy of Fallot in the neonatal versus non-neonatal period: a meta-analysis. Pediatr Cardiol. 2017;38(5):893–901.PubMedCrossRef
36.
go back to reference Polo López L, Centella Hernández T, López Menéndez J, Silva Guisasola J. Cirugía de pacientes con cardiopatía congénita en España en el período 2012-2016: registro de intervenciones de la Sociedad Española de Cirugía Torácica-Cardiovascular. Cir Cardiov. 2017;24(6):368–80. Polo López L, Centella Hernández T, López Menéndez J, Silva Guisasola J. Cirugía de pacientes con cardiopatía congénita en España en el período 2012-2016: registro de intervenciones de la Sociedad Española de Cirugía Torácica-Cardiovascular. Cir Cardiov. 2017;24(6):368–80.
37.
go back to reference Dedieu N, Fernández L, Garrido-Lestache E, Sánchez I, Jesus Lamas M. Effects of a cardiac rehabilitation program in patients with congenital heart disease. Open J Intern Med. 2014;04(01):22–7.CrossRef Dedieu N, Fernández L, Garrido-Lestache E, Sánchez I, Jesus Lamas M. Effects of a cardiac rehabilitation program in patients with congenital heart disease. Open J Intern Med. 2014;04(01):22–7.CrossRef
38.
go back to reference Calzolari A, Turchetta A, Biondi G, Drago F, De Ranieri C, Gagliardi G, et al. Rehabilitation of children after total correction of tetralogy of Fallot. Int J Cardiol. 1990;28(2):151–8.PubMedCrossRef Calzolari A, Turchetta A, Biondi G, Drago F, De Ranieri C, Gagliardi G, et al. Rehabilitation of children after total correction of tetralogy of Fallot. Int J Cardiol. 1990;28(2):151–8.PubMedCrossRef
39.
go back to reference Márquez-Calderón S, Villegas Portero R, Briones Pérez de la Blanca E, Sarmiento González-Nieto V, Reina Sánchez M, Sáinz Hidalgo I, Velasco Rami JA, Ridocci Soriano F. [Incorporation of cardiac rehabilitation programs and their characteristics in the Spanish National Health Service]. Rev Esp Cardiol. 2003;56(8):775–82.PubMedCrossRef Márquez-Calderón S, Villegas Portero R, Briones Pérez de la Blanca E, Sarmiento González-Nieto V, Reina Sánchez M, Sáinz Hidalgo I, Velasco Rami JA, Ridocci Soriano F. [Incorporation of cardiac rehabilitation programs and their characteristics in the Spanish National Health Service]. Rev Esp Cardiol. 2003;56(8):775–82.PubMedCrossRef
40.
go back to reference Kwon EN, Mussatto K, Simpson PM, Brosig C, Nugent M, Samyn MM. Children and adolescents with repaired tetralogy of Fallot report quality of life similar to healthy peers. Congenit Heart Dis. 2011;6(1):18–27.PubMedCrossRef Kwon EN, Mussatto K, Simpson PM, Brosig C, Nugent M, Samyn MM. Children and adolescents with repaired tetralogy of Fallot report quality of life similar to healthy peers. Congenit Heart Dis. 2011;6(1):18–27.PubMedCrossRef
41.
42.
go back to reference Khoshnood B, De Vigan C, Vodovar V, Goujard J, Lhomme A, Bonnet D, et al. Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with congenital heart disease in France, 1983–2000: a population-based evaluation. Pediatrics. 2005;115(1):95–101.PubMedCrossRef Khoshnood B, De Vigan C, Vodovar V, Goujard J, Lhomme A, Bonnet D, et al. Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with congenital heart disease in France, 1983–2000: a population-based evaluation. Pediatrics. 2005;115(1):95–101.PubMedCrossRef
43.
go back to reference Lee W, Smith RS, Comstock CH, Kirk JS, Riggs T, Weinhouse E. Tetralogy of Fallot: prenatal diagnosis and postnatal survival. Obstet Gynecol. 1995;86(4 Pt 1):583–8.PubMedCrossRef Lee W, Smith RS, Comstock CH, Kirk JS, Riggs T, Weinhouse E. Tetralogy of Fallot: prenatal diagnosis and postnatal survival. Obstet Gynecol. 1995;86(4 Pt 1):583–8.PubMedCrossRef
44.
go back to reference Plana MN, Zamora J, Suresh G, Fernandez-Pineda L, Thangaratinam S, Ewer AK. Pulse oximetry screening for critical congenital heart defects. Cochrane Neonatal Group, editor Cochrane Database Syst Rev 2018. Plana MN, Zamora J, Suresh G, Fernandez-Pineda L, Thangaratinam S, Ewer AK. Pulse oximetry screening for critical congenital heart defects. Cochrane Neonatal Group, editor Cochrane Database Syst Rev 2018.
45.
46.
go back to reference Naidu P, Grigg L, Zentner D. Mortality in adults with congenital heart disease. Int J Cardiol. 2017;245:125–30.PubMedCrossRef Naidu P, Grigg L, Zentner D. Mortality in adults with congenital heart disease. Int J Cardiol. 2017;245:125–30.PubMedCrossRef
47.
go back to reference Alexiou C, Mahmoud H, Al-Khaddour A, Gnanapragasam J, Salmon AP, Keeton BR, et al. Outcome after repair of tetralogy of Fallot in the first year of life. Ann Thorac Surg. 2001;71(2):494–500.PubMedCrossRef Alexiou C, Mahmoud H, Al-Khaddour A, Gnanapragasam J, Salmon AP, Keeton BR, et al. Outcome after repair of tetralogy of Fallot in the first year of life. Ann Thorac Surg. 2001;71(2):494–500.PubMedCrossRef
48.
go back to reference Jonsson H, Ivert T. Survival and clinical results up to 26 years after repair of tetralogy of Fallot. Scand J Thorac Cardiovasc Surg. 1995;29(2):43–51.PubMedCrossRef Jonsson H, Ivert T. Survival and clinical results up to 26 years after repair of tetralogy of Fallot. Scand J Thorac Cardiovasc Surg. 1995;29(2):43–51.PubMedCrossRef
49.
go back to reference Engelings CC, Helm PC, Abdul-Khaliq H, Asfour B, Bauer UMM, Baumgartner H, et al. Cause of death in adults with congenital heart disease - An analysis of the German National Register for congenital heart defects. Int J Cardiol. 2016;211:31–6.PubMedCrossRef Engelings CC, Helm PC, Abdul-Khaliq H, Asfour B, Bauer UMM, Baumgartner H, et al. Cause of death in adults with congenital heart disease - An analysis of the German National Register for congenital heart defects. Int J Cardiol. 2016;211:31–6.PubMedCrossRef
50.
go back to reference Verheugt CL, Uiterwaal CSPM, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk APJ, et al. Mortality in adult congenital heart disease. Eur Heart J. 2010;31(10):1220–9.PubMedCrossRef Verheugt CL, Uiterwaal CSPM, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk APJ, et al. Mortality in adult congenital heart disease. Eur Heart J. 2010;31(10):1220–9.PubMedCrossRef
51.
go back to reference Greutmann M, Tobler D. Changing epidemiology and mortality in adult congenital heart disease: looking into the future. Futur Cardiol. 2012;8(2):171–7.CrossRef Greutmann M, Tobler D. Changing epidemiology and mortality in adult congenital heart disease: looking into the future. Futur Cardiol. 2012;8(2):171–7.CrossRef
52.
go back to reference Afilalo J, Therrien J, Pilote L, Ionescu-Ittu R, Martucci G, Marelli AJ. Geriatric Congenital Heart Disease. 2011;58(14):7. Afilalo J, Therrien J, Pilote L, Ionescu-Ittu R, Martucci G, Marelli AJ. Geriatric Congenital Heart Disease. 2011;58(14):7.
53.
go back to reference Lara DA, Fixler DE, Ethen MK, Canfield MA, Nembhard WN, Morris SA. Prenatal diagnosis, hospital characteristics, and mortality in transposition of the great arteries: prenatal diagnosis in TGA. Birt Defects Res A Clin Mol Teratol. 2016;106(9):739–48.CrossRef Lara DA, Fixler DE, Ethen MK, Canfield MA, Nembhard WN, Morris SA. Prenatal diagnosis, hospital characteristics, and mortality in transposition of the great arteries: prenatal diagnosis in TGA. Birt Defects Res A Clin Mol Teratol. 2016;106(9):739–48.CrossRef
54.
go back to reference Lundström NR, Berggren H, Björkhem G, Jögi P, Sunnegårdh J. Centralization of pediatric heart surgery in Sweden. Pediatr Cardiol. 2000;21(4):353–7.PubMedCrossRef Lundström NR, Berggren H, Björkhem G, Jögi P, Sunnegårdh J. Centralization of pediatric heart surgery in Sweden. Pediatr Cardiol. 2000;21(4):353–7.PubMedCrossRef
55.
go back to reference Velleman PF. Definition and comparison of robust nonlinear data smoothing algorithms. J Am Stat Assoc. 1980;75(371):609–15.CrossRef Velleman PF. Definition and comparison of robust nonlinear data smoothing algorithms. J Am Stat Assoc. 1980;75(371):609–15.CrossRef
56.
go back to reference Besag J, York J, Molliè A. Bayesian image restoration, with two applications in spatial statistics. Ann Inst Stat Math. 1991;43(1):1–20.CrossRef Besag J, York J, Molliè A. Bayesian image restoration, with two applications in spatial statistics. Ann Inst Stat Math. 1991;43(1):1–20.CrossRef
Metadata
Title
Tetralogy of Fallot in Spain: a nationwide registry-based mortality study across 36 years
Authors
Laura Llamosas-Falcón
Eva Bermejo-Sánchez
Germán Sánchez-Díaz
Ana Villaverde-Hueso
Manuel Posada de la Paz
Verónica Alonso-Ferreira
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2019
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-019-1056-y

Other articles of this Issue 1/2019

Orphanet Journal of Rare Diseases 1/2019 Go to the issue